Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus

Globe Newswire - Press Release

All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here

SAN DIEGO, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that the OTO-313 Phase 2 trial in tinnitus demonstrated no clinically meaningful benefit versus placebo for primary and secondary endpoints across all timepoints.

Read more at globenewswire.com

Related Symbols

Symbol Last Chg %Chg
OTIC 0.0085 -0.1070 -92.64%
Otonomy Inc

Most Popular News

Investor checking market data by SAI SU PAW KA via Shutterstock 1
Forget Nvidia and Broadcom. This Forgotten Retail Stock Is a Top Performer in 2025.
Double explosure with businesss charts and financial district of megapolis city by Golden Dayz via Shutterstock 2
Stocks Climb Before the Open on Micron Boost Ahead of U.S. Inflation Data
A close-up shot of Warren Buffett_ Image by mark reinstein via Shutterstock_ 3
‘We’ll Be in These Stocks 10, 20 Years’: Warren Buffett’s $30 Billion Bet Gets a Big Boost as Bank of Japan Raises Rates to 30-Year High
Image of Warren E_ Buffett by Photo Agency via Shutterstock 4
No ‘Intelligence or Emotional Stability’ Required: Warren Buffett Warns Short-Term Markets Are a ‘Voting Machine,’ But Eventually Reflect Reality
A Palantir sign displayed on an office building by Poetra_RH via Shutterstock 5
How Much You’d Have If You Bet $10,000 on Palantir Stock in January and 1 Key PLTR Catalyst to Watch in 2026
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot